Search Results

You searched for : nonsmall  

	Roche’s Tecentriq approved by European Commission for metastatic non-small cell lung cancer Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options... May 08
	Imfinzi recommended for approval in the EU by CHMP for non-small cell lung cancer This new dosing option is consistent with the approved Imfinzi dosing in extensive-stage small cell lung cancer and once approved, will be available to ... Dec 15
	FDA grants priority review of Regeneron-Sanofi's Libtayo for advanced Non-small Cell Lung Cancer Libtayo is indicated for advanced non-smal cell cancer with PD-L1 Expression of ≥50%... Oct 31
	Roche receives US FDA approval for the cobas EGFR mutation test v2 Roche receives FDA approval for the cobas EGFR mutation test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with ... Oct 30
	Roche announces FDA approval of Gavreto (pralsetinib) for the treatment of lungs cancer Gavreto is used in treatment of adults with metastatic RET fusion-positive non-small cell lung cancer... Sep 08
	PharmAbcine signs a CMO contract with Binex for Olinvacimab production Binex will produce olinvacimab at its new 5,000L production line... Sep 03
	Thermo Fisher and Daiichi Sankyo joins hands : Non small cell cancer Two pharma giants come together for developing Global Companion Diagnostics for patients with NSCLC cancer... Jun 25
	Three-Year Survival Update: Pembrolizumab Effective as First-Line Therapy for Advanced Non-Small Cell Lung Cancer First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic ... Sep 10
8 Matching result(s) found!

Trending Now
	The Value of Risk Communication in Public HealthOctober 08, 2026
	What Makes a Reliable Health Screening Programme?October 08, 2026
	How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
	Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
	Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
	Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
	How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
	AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
	AI and Patient Consent in India: Who Is Responsible?October 06, 2026
	Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
	Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
	Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
	Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
	Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
	Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
	Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
	Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
	Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
	The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
	Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026